Aandelen in “Productie van biologische producten”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Cardiff Oncology Inc |
19/12 | 2,570 USD
+2,80% |
+2,80% |
|
CASI Pharmaceuticals Inc |
19/12 | 0,810 USD
-2,59% |
-2,59% |
|
Cel-Sci Corp. |
19/12 | 4,910 USD
-10,73% |
-10,73% |
|
Celldex Therapeutics Inc. |
19/12 | 25,600 USD
+1,23% |
+1,23% |
Cellectis |
19/12 | 3,730 EUR
+6,12% |
+6,12% |
|
Cellectis |
19/12 | 4,370 USD
+5,05% |
+5,05% |
|
Champions Oncology Inc |
19/12 | 7,220 USD
0,00% |
0,00% |
|
Cidara Therapeutics Inc |
19/12 | 220,800 USD
+0,20% |
+0,20% |
|
Coherus Biosciences Inc |
19/12 | 1,360 USD
0,00% |
0,00% |
|
CRISPR Therapeutics AG |
19/12 | 55,860 USD
+1,86% |
+1,86% |
|
Curis Inc |
19/12 | 1,070 USD
-6,96% |
-6,96% |